Neisseria meningitidis, an exclusive pathogen of humans, remains the leadin
g worldwide cause of meningitis and fatal sepsis, usually in otherwise heal
thy individuals. In recent years, significant advances have improved our un
derstanding of the epidemiology and genetic basis of meningococcal disease
and led to progress in the development of the next generation of meningococ
cal vaccines. This review summarizes current knowledge of the human suscept
ibility to and the epidemiology and molecular pathogenesis of meningococcal
disease. (C) 2000 Editions scientifiques et medicales Elsevier SAS.